Efficacy and safety of ayurvedic intervention (Sarpgandha Mishran) vs amlodipine for Stage-I primary hypertension- study protocol for a prospective Double-Dummy, Double-Blind, placebo-controlled Randomized Clinical Trial
The trial is prospectively registered with the Clinical Trial Registry of India [CTRI/2021/12/038589], dated 13.12.2021.
Authors
- Sophia Jameela (ORCID: https://orcid.org/0000-0001-6685-3610)
- Narayanam Srikanth (ORCID: https://orcid.org/0000-0002-3976-4978)
- Rajiv Narang (ORCID: https://orcid.org/0000-0001-9634-5887)
- Babita Yadav (ORCID: https://orcid.org/0000-0003-4524-2452)
- Shruti Khanduri (ORCID: https://orcid.org/0000-0001-6310-6505)
- Bharti Gupta (ORCID: https://orcid.org/0000-0001-6827-2983)
- Drishya Dinesh
- Arti Srivastava (ORCID: https://orcid.org/0000-0003-2774-0642)
- Richa Bhardwaj
- Dharamvir Singh Arya (ORCID: https://orcid.org/0000-0002-9249-9237)
- Sakshi Sharma (ORCID: https://orcid.org/0000-0003-4749-1559)
- BCS Rao
Institutions
- Central Council for Research in Ayurvedic Science (IN)
- All India Institute of Medical Sciences (IN)
- National Institute of Malaria Research (IN)
Publication Details
- Journal
- BMC Complementary Medicine and Therapies
- Published
- 2025-03-01
- DOI
- https://doi.org/10.1186/s12906-025-04802-4
- Citations
- 1
- Primary Topic
- Blood Pressure and Hypertension Studies
- Type
- article
- Field-Weighted Citation Impact
- 1.39